AI summary by TwinMind

Why is it so hard to cure the common cold?

TED-Ed

5m 17s

ViroPharma Pleconaril Clinical Trial (2000)

  • ViroPharma tested pleconaril pill for common cold treatment
  • Drug helped many patients initially
  • 7 patients developed mutated virus variants almost completely resistant to pleconaril within days
  • Virus mutated faster than years of R&D could anticipate

Common Cold Biology and Immune Response

  • Without immune system: cold spreads to lungs → tissue destruction → asphyxiation
  • Millions with compromised immunity/immunosuppressants face deadly risk from "minor" infections
  • Healthy adults catch 150+ colds lifetime
  • 8+ different virus families cause colds, each with species/subtypes
  • Viruses enter via breathing → immune system frontline defenses create symptoms:
    • Mucus/dripping nose: traps and flushes virus
    • Fever: raises temperature to slow viral replication
    • Inflammation: widens blood vessels, recruits white blood cells

Rhinovirus as Primary Target

  • Single family causes 30-50% of all colds: rhinovirus
  • Eliminating rhinovirus would significantly impact common cold

Vaccine Development Attempts

  • Two main approaches: vaccines and antiviral drugs
  • William Price 1957 rhinovirus vaccine trial:
    • 50 vaccinated kids vs 50 placebo
    • Rhinovirus outbreak occurred
    • Vaccinated group: 3 got sick
    • Placebo group: 23 got sick (8x higher rate)
  • Later trials showed zero protection
  • Problem: rhinovirus has 169+ subtypes
  • Price's vaccine only protected against 1-few subtypes, not broadly protective

Vaccine Success Examples and Challenges

  • mRNA COVID vaccines: broad protection against original virus and variants
  • No broadly protective vaccine exists for rhinovirus or other cold viruses

Antiviral Drug Challenges

  • Viruses hijack human cellular machinery
  • Difficult creating molecules toxic to virus but not human
  • Viruses can mutate away from drug effectiveness
  • Example: pleconaril resistance developed rapidly

Historical Viral Combat Success Stories

  • Smallpox eradication: effective vaccine + no animal reservoir + low mutation rate
  • HIV: extremely high mutation rate (every possible single-letter mutation possible daily in untreated individual)
    • No vaccine after decades of attempts
    • Effective drug cocktail prevents easy mutation escape

Future Prospects

  • Currently stuck with colds
  • Recent breakthroughs: mRNA vaccines, CRISPR
  • CRISPR potential as antiviral:
    • Originally evolved in bacteria as viral defense
    • COVID-19 pandemic research: CRISPR degraded coronavirus/influenza genomes in lung cells
    • System called PAC-MAN (Prophylactic Antiviral CRISPR in huMAN cells)

TwinMind

Get summaries like this for your own meetings

TwinMind takes notes in the background during meetings, lectures, and calls, then writes the summary for you.

Free plan to get started

No bot joins your calls

Phone, desktop & Chrome apps

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome